SPDR S&P Pharmaceuticals (XPH) 106.21 $XPH
The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals ETF, iShares U.S. Pharmaceuticals and Market Vectors Pharmaceutical
PR Newswire - Mon Aug 25, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Powershares Dynamic Pharmaceuticals ETF (AMEX
JP-Free Report), SPDR S&P Pharmaceuticals ETF (AMEX:XPH-Free Report), iShares U.S. Pharmaceuticals (AMEX:IHE-Free Report) and Market Vectors Pharmaceutical (AMEX PH-Free Report).
Pharma ETF Investing 101 - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 9:00AM CDT
Rising demand from emerging markets and new products will continue to drive growth in the pharma industry.
Bet On This Top Ranked Medical Device ETF - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Aug 11, 5:07AM CDT
This top ranked ETF may be a good defensive bet in the current volatile market environment.
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 1:38PM CDT
The trend of tax inversion has been mostly prevalent in the healthcare sector. Medical devices and pharma companies are rapidly buying foreign competitors. Mutual funds holding these stocks in their portfolio should thus experience solid uplift in the near term.
XPH, AKRX, PRGO, QCOR: ETF Outflow Alert
ETFChannel.com - Mon Jul 28, 10:29AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Pharmaceuticals ETF where we have detected an approximate $44.5 million dollar outflow -- that's a 4.8%...
XPH Crushing the Pharma ETFs Competition - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Jun 20, 1:00PM CDT
This ETF is considered a solid pick given its strong fundamentals and the growing pharma space.
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture
ACCESSWIRE - Mon Mar 10, 8:01AM CDT
Whitefish, MT / March 10, 2014 / The healthcare industry has been attracting record amounts of capital in 2014, driven by biotechnology and pharmaceutical companies bringing new products to market. In fact, more than half of all money flowing into U.S. sector-focused ETFs, or $4.06 billion through February 28th, was placed in healthcare ETFs, according to data compiled by Bloomberg.
3 Pharma ETFs Beating the Market - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 11:00AM CST
Pharma ETFs continue their strong momentum this year too after an impressive performance in 2013.
Top Ranked Healthcare ETF in Focus: XPH - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Feb 12, 7:01AM CST
This top ranked fund could be a great way to target the strength in the health care market.
Obamacare Boosts Health Funds
at The Street - Mon Jan 27, 10:26AM CST
Pharmaceutical and hospital stocks rally as more consumers gain insurance.
SPDR S&P Pharmaceuticals ETF Up 31.8% Since SmarTrend Uptrend Call (XPH)
Comtex SmarTrend(R) - Wed Jan 22, 4:47PM CST
SmarTrend identified an Uptrend for SPDR S&P Pharmaceuticals ETF (AMEX:XPH) on July 1st, 2013 at $71.31. In approximately 7 months, SPDR S&P Pharmaceuticals ETF has returned 31.78% as of today's recent price of $93.97.
SPDR S&P Pharmaceuticals ETF Shares Up 30.6% Since SmarTrend's Buy Recommendation (XPH)
Comtex SmarTrend(R) - Wed Jan 15, 11:01AM CST
SmarTrend identified an Uptrend for SPDR S&P Pharmaceuticals ETF (AMEX:XPH) on July 1st, 2013 at $71.31. In approximately 7 months, SPDR S&P Pharmaceuticals ETF has returned 30.58% as of today's recent price of $93.12.
Time for Pharmaceutical ETFs? - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Aug 20, 11:10AM CDT
If investors need a health care ETF should they be looking at pharma funds?
The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals ETF, iShares U.S. Pharmaceuticals and Market Vectors Pharmaceutical
PR Newswire - Mon Aug 25, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Powershares Dynamic Pharmaceuticals ETF (AMEX
JP-Free Report), SPDR S&P Pharmaceuticals ETF (AMEX:XPH-Free Report), iShares U.S. Pharmaceuticals (AMEX:IHE-Free Report) and Market Vectors Pharmaceutical (AMEX PH-Free Report). Pharma ETF Investing 101 - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 9:00AM CDT
Rising demand from emerging markets and new products will continue to drive growth in the pharma industry.
Bet On This Top Ranked Medical Device ETF - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Aug 11, 5:07AM CDT
This top ranked ETF may be a good defensive bet in the current volatile market environment.
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 1:38PM CDT
The trend of tax inversion has been mostly prevalent in the healthcare sector. Medical devices and pharma companies are rapidly buying foreign competitors. Mutual funds holding these stocks in their portfolio should thus experience solid uplift in the near term.
XPH, AKRX, PRGO, QCOR: ETF Outflow Alert
ETFChannel.com - Mon Jul 28, 10:29AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Pharmaceuticals ETF where we have detected an approximate $44.5 million dollar outflow -- that's a 4.8%...
XPH Crushing the Pharma ETFs Competition - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Jun 20, 1:00PM CDT
This ETF is considered a solid pick given its strong fundamentals and the growing pharma space.
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture
ACCESSWIRE - Mon Mar 10, 8:01AM CDT
Whitefish, MT / March 10, 2014 / The healthcare industry has been attracting record amounts of capital in 2014, driven by biotechnology and pharmaceutical companies bringing new products to market. In fact, more than half of all money flowing into U.S. sector-focused ETFs, or $4.06 billion through February 28th, was placed in healthcare ETFs, according to data compiled by Bloomberg.
3 Pharma ETFs Beating the Market - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 11:00AM CST
Pharma ETFs continue their strong momentum this year too after an impressive performance in 2013.
Top Ranked Healthcare ETF in Focus: XPH - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Feb 12, 7:01AM CST
This top ranked fund could be a great way to target the strength in the health care market.
Obamacare Boosts Health Funds
at The Street - Mon Jan 27, 10:26AM CST
Pharmaceutical and hospital stocks rally as more consumers gain insurance.
SPDR S&P Pharmaceuticals ETF Up 31.8% Since SmarTrend Uptrend Call (XPH)
Comtex SmarTrend(R) - Wed Jan 22, 4:47PM CST
SmarTrend identified an Uptrend for SPDR S&P Pharmaceuticals ETF (AMEX:XPH) on July 1st, 2013 at $71.31. In approximately 7 months, SPDR S&P Pharmaceuticals ETF has returned 31.78% as of today's recent price of $93.97.
SPDR S&P Pharmaceuticals ETF Shares Up 30.6% Since SmarTrend's Buy Recommendation (XPH)
Comtex SmarTrend(R) - Wed Jan 15, 11:01AM CST
SmarTrend identified an Uptrend for SPDR S&P Pharmaceuticals ETF (AMEX:XPH) on July 1st, 2013 at $71.31. In approximately 7 months, SPDR S&P Pharmaceuticals ETF has returned 30.58% as of today's recent price of $93.12.
Time for Pharmaceutical ETFs? - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Aug 20, 11:10AM CDT
If investors need a health care ETF should they be looking at pharma funds?
